Financial Results Summary

Standalone Results (Q1 FY27):

  • Revenue from operations: ₹2,071.04 million (vs ₹1,971.30 million in Q4 FY26; ₹2,199.06 million in Q1 FY25)
  • Total income: ₹2,284.89 million
  • Profit before tax: ₹975.23 million
  • Total tax expense: ₹242.32 million
  • Profit for the period: ₹732.91 million
  • Basic EPS: ₹6.90
  • Diluted EPS: ₹6.89

Consolidated Results (Q1 FY27):

  • Revenue from operations: ₹2,684.32 million
  • Total income: ₹2,906.50 million
  • Profit before tax: ₹975.51 million
  • Total tax expense: ₹242.01 million
  • Profit for the period: ₹733.50 million
  • Basic EPS: ₹6.90
  • Diluted EPS: ₹6.90

Dividend Declaration

  • Final dividend declared for financial year 2025-2026
  • Record date: Saturday, September 5, 2026
  • Payment date: Wednesday, September 30, 2026
  • Register of Members and Share Transfer Books to be closed from September 5, 2026 to September 12, 2026 (both days inclusive)

Management Changes

  • Mr. Krishnakumar Satyanarain Saboo (DIN: 11863005) co-opted as Additional Director
  • Recommended for appointment as Whole-time Director for 5 years from August 1, 2026 to July 31, 2031
  • Appointed as Factory Occupier effective August 1, 2026
  • Profile: 62 years old, B.Sc. Tech (ICT) from University of Bombay, Bachelor of Science (Special) in Chemistry from South Gujarat University, 37 years experience in production planning, process improvement, project management
  • Currently serves as Group President (Operations) with 11 years association with the company

Subsidiary Activities

  • Approval for incorporation of wholly-owned foreign subsidiary in Netherlands by Clean Fino-Chem Limited (WOS of Clean Science)
  • Initial capital: EUR 50,000 (or INR equivalent) to be infused in one or more tranches
  • Share price: EUR 1 per share
  • Business: Selling/distribution/trading/job work of specialty chemicals and related products
  • No governmental approvals required for incorporation

Corporate Calendar

  • 23rd Annual General Meeting to be held on Saturday, September 12, 2026 through Video Conferencing/Other Audio-Visual Means

Additional Financial Information

  • During quarter ended June 30, 2026, 5,221 equity shares of ₹1 each fully paid-up were allotted upon exercise of vested stock options under ESOP 2021
  • Q4 FY26 figures are balancing figures between audited annual figures and unaudited nine-month figures
  • Executive Directors voluntarily forgone substantial portion of performance bonus entitlement in Q4 FY26, resulting in lower employee benefits expense that quarter

Strategic Collaboration

Clean-Fino Chem Limited entered into agreement on July 16, 2026 with Geneus Chem AG (Switzerland) for:

  • Long-term strategic collaboration for manufacturing and supply of advanced grades of HALS Products on worldwide exclusive basis
  • Includes minimum offtake commitments and pricing mechanism
  • Geneus Chem AG to issue warrants exercisable within 4 years from date of issue
  • Upon exercise, subsidiary will acquire 25% share capital of Geneus Chem AG on fully diluted basis at nominal price

Auditor Review

  • Financial results subjected to limited review by Price Waterhouse Chartered Accountants LLP
  • Unmodified conclusion issued on both standalone and consolidated results
  • Review conducted in accordance with Standard on Review Engagements (SRE) 2410